THE PROGRESSION OF HIV DISEASE IN A HEMOPHILIC COHORT FOLLOWED FOR 12 YEARS

被引:30
作者
SABIN, C
PHILLIPS, A
ELFORD, J
GRIFFITHS, P
JANOSSAY, G
LEE, C
机构
[1] UNIV LONDON ROYAL FREE HOSP, CTR HAEMOPHILIA, DEPT HAEMATOL, LONDON NW3 2QG, ENGLAND
[2] UNIV LONDON ROYAL FREE HOSP, DEPT PUBL HLTH & PRIMARY CARE, LONDON NW3 2QG, ENGLAND
[3] UNIV LONDON ROYAL FREE HOSP, DEPT VIROL, LONDON NW3 2QG, ENGLAND
[4] UNIV LONDON ROYAL FREE HOSP, DEPT IMMUNOL, LONDON NW3 2QG, ENGLAND
[5] UNIV COLL & MIDDLESEX SCH MED, ACAD DEPT GENITO URINARY MED, LONDON, ENGLAND
关键词
D O I
10.1111/j.1365-2141.1993.tb08290.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A cohort of haemophilic patients who seroconverted to HIV-1 between October 1979 and July 1985 has been followed to 1 January 1992. The median age at initial seropositivity was 24 years with a range of 2.77 years. By January 1992, 38/111 (34%) had developed AIDS and 39/111 (35%) had died (four of liver failure including one hepatoma). Using Kaplan-Meier plots, the calculated progression to AIDS at 12 years is 45% (95% CI 31, 58): for age > 25 years 63% (9 5% CI 45, 82), age < 25 years 32% (95% CI 15, 48) P=0.0001; CMV positive 68% (95% CI 48, 87) CMV -ve 20% (95% CI 8.32) P=0.0009. The 12-year progression rate to CD4+ 0.2 or AIDS is 66% (95%Cl 55, 76).21/34 (63%) of patients who are p24 antigen positive have developed AIDS compared to 17/77 (22%) who are p24 antigen negative (= 0.0001). 19/34 (56%) and 20/77 (23%) of those p24 positive and negative respectively have died (P=0.007). Before antiviral and prophylactic treatment for asymptomatic patients there were nine AIDS cases in 3.84 years experience with CD4+ <0.05 (1/0.43 years) and since treatment, 10 AIDS cases in 18.22 years (1/1.8 years). Age, CMV status and p24 remain strongly predictive of disease progression. Treatment appears to reduce the incidence of AIDS.
引用
收藏
页码:330 / 333
页数:4
相关论文
共 23 条
[21]  
WEBSTER A, 1992, CLIN EXP IMMUNOL, V88, P6
[22]  
1987, MMWR, V36, P15
[23]  
1992, MMWR, V40, P787